The verdict
Our read at a glance.
Whether a plant and insect steroid with no androgen receptor activity produces meaningful muscle gain in humans.
- The signal
- The interesting human data point is a controlled study reporting performance enhancement with ecdysterone in resistance-trained subjects, with effect sizes large enough that the authors raised the question of whether it should be prohibited in sport, and it was subsequently placed under monitoring. Around that sit registered trials of 20-hydroxyecdysone in obesity and prediabetes, chemistry work on the minor ecdysteroids of Ajuga turkestanica, reviews of phytoecdysteroid biology, and human excretion work following spinach consumption, which is where dietary ecdysterone actually comes from. Independent replication of the performance finding is thin.
- The unknown
- Both whether the effect is real at scale, and what people are actually taking. Independent analyses of retail turkesterone products have repeatedly found quantities far below label, and much of the supportive human data concerns ecdysterone rather than turkesterone specifically.
- Our read
- The most interesting supplement claim in this category and the one most damaged by its own market. One good trial, real enough to attract anti-doping attention, attached to products that repeatedly test as not containing the ingredient. Before asking whether turkesterone works, ask whether the bottle has any in it.
The mechanism
How it works.
Ecdysteroids are the hormones insects use to trigger moulting, and closely related compounds occur in some plants, including spinach and Ajuga turkestanica. The reason they are interesting is that they appear to be anabolic in mammals without touching the androgen receptor - which is what would allow muscle effects without testosterone suppression, prostate effects or the need for post-cycle recovery. The proposed mechanism is signalling through the oestrogen receptor beta, activating the PI3K/Akt pathway that drives muscle protein synthesis, rather than through classical androgen signalling. That is a genuinely different route, and it is why the claim is not absurd on its face. The gap is between a plausible receptor mechanism plus one positive trial, and the confident anabolic marketing built on top of it.
Safety & regulatory boundary
The consequential part.
Not approved medicines. Sold as supplements with no manufacturing standard for identity or potency, and product-content analyses are the weakest link in the whole case. Ecdysterone has been placed on WADA's monitoring programme, which means it is watched rather than banned. Short-term tolerability in the published human work appears reasonable, but no long-term safety data exist.
What's next
What we're watching.
Independent replication of the ecdysterone performance trial, and any analytical survey that finds retail turkesterone products containing what they claim.
Context
Why this is discussed.
They are marketed as anabolic without the hormonal downside - no receptor suppression, no post-cycle therapy - which if true would be the best trade in this category.
The evidence base
13 cited references.
Registered trials3
ClinicalTrials.gov · PHASE2 · NOT_YET_RECRUITING · 2026-07
ClinicalTrials.gov · PHASE2 · COMPLETED · 2017-02-07
ClinicalTrials.gov · NA · UNKNOWN · 2019-02-06
Indexed literature (PubMed)10
Todorova V et al. · Nutrients · 2024
Isenmann E et al. · Arch Toxicol · 2019
Guibout L et al. · Phytochem Anal · 2015
Dinan L · Phytochemistry · 2001
Yuliandra T et al. · Mol Nutr Food Res · 2023
Baev AY et al. · J Steroid Biochem Mol Biol · 2022
Dinan L et al. · J Insect Sci · 2003
Tashmukhamedova MA et al. · Vopr Med Khim · 1986
Báthori M et al. · Curr Med Chem · 2000
Kwiatkowska D et al. · Drug Test Anal · 2024
Keep reading